Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling
Background: Milk-derived biopeptides have reported in vitro dipeptidyl-peptidase IV (DPP-IV) inhibition, suggesting a glycemic-regulatory effect in Type 2 Diabetes Mellitus (T2DM). Nonetheless, the therapeutic application of these nutraceuticals is limited by the scarcity of knowledge regarding the...
Enregistré dans:
Auteurs principaux: | Jorge Andrés Barrero, Fabio Cabrera, Claudia Marcela Cruz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Universidad de Antioquia
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b54a861ec7f74571ad98ecd6286ca34c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Effect of Bioactive Polyphenols from <i>Anacardium occidentale</i> Linn. Leaves on α-Amylase and Dipeptidyl Peptidase IV Activities
par: Nur Imanina Abdullah Thaidi, et autres
Publié: (2020) -
Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
par: Nehru Sai Suresh Chalichem, et autres
Publié: (2021) -
Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
par: Gagik Radikovich Galstyan, et autres
Publié: (2015) -
Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates
par: Shitao Zhang, et autres
Publié: (2021) -
Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
par: Lin YH, et autres
Publié: (2019)